Microdialysis: Current applications in clinical pharmacokinetic studies and its potential role in the future

Clinical Pharmacokinetics

Volumn 44, Issue 9, 2005, Pages 895-913

  Joukhadar, Christian ^a   Müller, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; BETA LACTAM ANTIBIOTIC; BETAMETHASONE; CAPECITABINE; CARBAPENEM DERIVATIVE; CARBOPLATIN; CYTOTOXIC AGENT; DACARBAZINE; ENOXACIN; EPIRUBICIN; FLUOROURACIL; FOSFOMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; KETOLIDE; LOCAL ANESTHETIC AGENT; MACROLIDE; MELPHALAN; METHOTREXATE; METHOXSALEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZOLIDINONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SALICYLIC ACID; TRANILAST; UNINDEXED DRUG;

ANALYTIC METHOD; BLOOD ANALYSIS; CLINICAL EXAMINATION; DECISION MAKING; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG INDUSTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMAGING SYSTEM; INTERSTITIAL FLUID; MICRODIALYSIS; MOLECULAR SIZE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE INJURY;

ANIMALS; CHEMISTRY, CLINICAL; HUMANS; MICRODIALYSIS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 24344499438     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200544090-00002     Document Type: Review

References (162)

1. Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for failure in patients with septic shock. Crit Care Med 2001; 29: 385-91
2. Tegeder I, Schmidtko A, Brautigam L, et al. Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther 2002; 71: 325-33
3. Brunner M, Pernerstorfer T, Mayer BX, et al. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 2000; 28: 1754-9
4. Namour F, Sultan E, Pascual MH, et al. Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration. J Antimicrob Chemother 2002; 49: 1035-8
5. Walstad RA, Hellum KB, Thurmann-Nielsen E, et al. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid. J Antimicrob Chemother 1986; 17 Suppl. C: 71-80
6. Mazzei T, Novelli A, Esposito S, et al. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients. J Chemother 2000; 12: 306-13
7. Richer M, Allard S, Manseau L, et al. Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses. Antimicrob Agents Chemother 1995; 39: 1082-6
8. Borg N, Gotharson E, Benfeldt E, et al. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm Venereol 1999; 79: 274-7
9. Holm SE. Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl 1978; 13: 47-51
10. Varela JE, Cohn SM, Brown M, et al. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries. J Antimicrob Chemother 2000; 45: 337-42
11. Licitra CM, Brooks RG, Sieger BE. Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection. Antimicrob Agents Chemother 1987; 31: 805-7
12. Birmingham MC, Guarino R, Heller A, et al. Ciprofloxacin concentrations in lung tissue following a single 400mg intravenous dose. J Antimicrob Chemother 1999; 43 Suppl. A: 43-8
13. Daschner F. Tobramycin serum levels and tissue content in children. Chemotherapy 1977; 23: 293-8
14. Bergeron MG. The pharmacokinetics and tissue penetration of the fluoroquinolones. Clin Invest Med 1989; 12: 20-7
15. Sidhu P, Shojaee Aliabadi F, Andrews M, et al. Tissue chamber model of acute inflammation in farm animal species. Res Vet Sci 2003; 74: 67-77
16. Cheng Z, Nolan AM, McKellar QA. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep. Inflammation 1998; 22: 353-66
17. Bergan T. Kinetics of tissue penetration: are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy? Scand J Infect Dis Suppl 1978; 14: 36-46
18. Rylander M, Holm SE, Norrby R, et al. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages. Scand J Infect Dis Suppl 1978; 13: 52-7
19. Petrakis I, Vrachassotakis N, Tsatsakis A, et al. Prospective study of preincisional single-dose ceftriaxone in reducing post-operative wound infection in high risk of infection patients. Eur Rev Med Pharmacol Sci 1998; 2: 141-5
20. Blaser J, Rieder HL, Luthy R. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother 1991; 35: 837-9
21. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11: 470-82
22. Barza M, Cuchural G. General principles of antibiotic tissue penetration. J Antimicrob Chemother 1985; 15 Suppl. A: 59-75
23. de Lange EC, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 2002; 41: 691-703
24. Curry FE. Determinants of capillary permeability: a review of mechanisms based on single capillary studies in the frog. Circ Res 1986; 59: 367-80
25. Renkin EM. Multiple pathways of capillary permeability. Circ Res 1977; 41: 735-43
26. Michel CC. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol 1980; 309: 341-55
27. Joukhadar C, Klein N, Frossard M, et al. Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther 2001; 70: 532-9
28. Clough GF, Boutsiouki P, Church MK, et al. Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002; 302: 681-6
29. Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148: 434-43
30. Stahle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis: III. Extracellular concentration of caffeine in adipose tissue in man. Life Sci 1991; 49: 1853-8
31. Lonnroth P. Microdialysis: a new and promising method in clinical medicine. J Intern Med 1991; 230: 363-4
32. Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993; 31 Suppl. D: 1-16
33. Brunner M, Stabeta H, Moller JG, et al. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 2002; 46: 3724-30
34. Frossard M, Joukhadar C, Steffen G, et al. Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor-inhibition on transcapillary glucose transport in humans. Life Sci 2000; 66: PL147-54
35. Langberg H, Olesen JL, Gemmer C, et al. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 2002; 542: 985-90
36. Langberg H, Olesen JL, Bulow J, et al. Intra- and peri-tendinous microdialysis determination of glucose and lactate in pigs. Acta Physiol Scand 2002; 174: 377-80
37. Kennergren C, Mantovani V, Strindberg L, et al. Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest. Am J Physiol Endocrinol Metab 2003; 284: E788-94
38. Kennergren C, Mantovani V, Lonnroth P, et al. Extracellular amino acids as markers of myocardial ischemia during cardioplegic heart arrest. Cardiology 1999; 91: 31-40
39. Mindermann T, Zimmerli W, Gratzl O. Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother 1998; 42: 2626-9
40. Thorsen K, Kristoffersson AO, Lerner UH, et al. In situ microdialysis in bone tissue: stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest 1996; 98: 2446-9
41. Herkner H, Muller MR, Kreischitz N, et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med 2002; 165: 273-6
42. Blochl-Daum B, Muller M, Meisinger V, et al. Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis. Br J Cancer 1996; 73: 920-4
43. Mader RM, Schrolnberger C, Rizovski B, et al. Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer. Br J Cancer 2003; 88: 782-7
44. Müller M, Mader RM, Steiner B, et al. 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res 1997; 57: 2598-601
45. Muller M, Brunner M, Schmid R, et al. Interstitial methotrexate kinetics in primary breast cancer lesions. Cancer Res 1998; 58: 2982-5
46. Joukhadar C, Klein N, Mader RM, et al. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Cancer 2001; 92: 2190-6
47. Delgado JM, DeFeudis FV, Roth RH, et al. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 1972; 198: 9-21
48. Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228-31
49. Brunner M, Hollenstein U, Delacher S, et al. Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob Agents Chemother 1999; 43: 1307-9
50. Muller M, Mascher H, Kikuta C, et al. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62: 293-9
51. Hollenstein U, Brunner M, Mayer BX, et al. Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers. Clin Pharmacol Ther 2000; 67: 229-36
52. Tossman U, Ungerstedt U. Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 1986; 128: 9-14
53. Frossard M, Joukhadar C, Erovic BM, et al. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother 2000; 44: 2728-32
54. Brunner M, Joukhadar C, Schmid R, et al. Validation of urea as an endogenous reference compound for the in vivo calibration of microdialysis probes. Life Sci 2000; 67: 977-84
55. Muller M, Rastelli C, Ferri P, et al. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998; 25: 1833-6
56. Muller M, Schmid R, Georgopoulos A, et al. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57: 371-80
57. Hsiao JK, Ball BA, Morrison PF, et al. Effects of different semipermeable membranes on in vitro and in vivo performance of microdialysis probes. J Neurochem 1990; 54: 1449-52
58. Benveniste H, Hansen AJ, Ottosen NS. Determination of brain interstitial concentrations by microdialysis. J Neurochem 1989; 52: 1741-50
59. Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol 1994; 102: 807-11
60. Hickner RC, Ekelund U, Mellander S, et al. Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 1995; 79: 638-47
61. Groth LJA. In vitro microdialysis of hydrophilic and lipophilic compounds. Anal Chim Acta 1997; 355: 75-83
62. Benfeldt E, Groth L. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 1998; 78: 274-8
63. Muller M, Schmid R, Wagner O, et al. In vivo characterization of transdermal drug transport by microdialysis. J Control Release 1995; 37: 49-57
64. Mayer BX, Hollenstein U, Brunner M, et al. Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteers. Electrophoresis 2000; 21: 1558-64
65. Buerger C, Joukhadar C, Muller M, et al. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 796: 155-64
66. Neckel U, Joukhadar C, Frossard M, et al. Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by HPLC. Anal Chim Acta 2002; 463: 199-206
67. Kurosaki Y, Nakamura S, Shiojiri Y, et al. Lipo-microdialysis: a new microdialysis method for studying the pharmacokinetics of lipophilic substances. Biol Pharm Bull 1998; 21: 194-6
68. Carneheim C, Stahle L. Microdialysis of lipophilic compounds: a methodological study. Pharmacol Toxicol 1991; 69: 378-80
69. FDA. Guidance for industry: developing antimicrobial drugs: general considerations for clinical trials [online]. Available from URL: http://www.fda.gov/cder/guidance/2580dft.pdf [Accessed 2005 Jun 29]
70. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Anti-infective drugs ad visory committee meeting, 64th meeting: guidance documents on developing antimicrobial drugs: general considerations and individual indications [online]. Available from URL: http://www.fda.gov/cder/present/anti-infective798/073198.pdf [Accessed 2005 May 23]
71. Herkner H, Klein N, Joukhadar C, et al. Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest 2003; 33: 141-6
72. Legat FJ, Maier A, Dittrich P, et al. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother 2003; 47: 371-4
73. Lorentzen H, Kallehave F, Kolmos HJ, et al. Gentamicin concentrations in human subcutaneous tissue. Antimicrob Agents Chemother 1996; 40: 1785-9
74. Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996; 40: 2703-9
75. Muller M, Brunner M, Hollenstein U, et al. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother 1999; 43: 2056-8
76. Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 2003; 47: 3548-53
77. Joukhadar C, Stass H, Muller-Zellenberg U, et al. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother 2003; 47: 3099-103
78. de PA, Brunner M, Eichler HG, et al. Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans. J Clin Pharmacol 2002; 42: 403-11
79. Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002; 30: 1478-82
80. Liu P, Muller M, Grant M, et al. Interstitial tissue concentrations of cefpodoxime. J Antimicrob Chemother 2002; 50 Suppl.: 19-22
81. Gattringer R, Urbauer E, Traunmuller F, et al. Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers. Antimicrob Agents Chemother 2004 Dec; 48 (12): 4650-3
82. Dehghanyar P, Burger C, Zeitlinger M, et al. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother 2005 Jun; 49 (6): 2367-71
83. Plock N, Buerger C, Kloft C. Successful management of discovered pH dependence in vancomycin recovery studies: novel HPLC method for microdialysis and plasma samples. Biomed chromatogr 2005 Apr; 19 (3): 237-44
84. Hollenstein UM, Brunner M, Schmid R, et al. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001; 25: 354-8
85. Brunner M, Reinprecht A, Illievich U, et al. Penetration of fosfomycin into the parenchyma of human brain: a case study in three patients. Br J Clin Pharmacol 2002; 54: 548-50
86. Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003; 51: 1247-52
87. Tegeder I, Brautigam L, Podda M, et al. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen. Clin Pharmacol Ther 2002; 71: 153-61
88. Kearney BP, Aweeka FT. The penetration of anti-infectives into the central nervous system. Neurol Clin 1999; 17: 883-900
89. Barza M. Anatomical barriers for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1993; 12 Suppl. 1: S31-5
90. Drach GW. Prostatitis: man's hidden infection. Urol Clin North Am 1975; 2: 499-520
91. Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol 1993; 111: 492-4
92. Barza M, Lynch E, Baum JL. Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits. Arch Ophthalmol 1993; 111: 121-5
93. Heikkinen T, Laine K, Neuvonen PJ, et al. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770-5
94. Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981; 3: 67-73
95. Rebuck AS, Braude AC. Assessment of drug disposition in the lung. Drugs 1984; 28: 544-53
96. Potschka H, Fedrowitz M, Loscher W. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 2001; 12: 3557-60
97. Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 2001; 1: 189-99
98. Sukhai M, Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci 2000; 3: 268-80
99. Huovinen P. Macrolide-resistant group A streptococcus: now in the United States. N Engl J Med 2002; 346: 1243-5
100. Presant CA, Wolf W, Waluch V, et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 1994; 343: 1184-7
101. Hyatt JM, McKinnon PS, Zimmer GS, et al. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome: focus on antibacterial agents. Clin Pharmacokinet 1995; 28: 143-60
102. Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis Suppl 1978; 14: 262-6
103. Palsmeier RK, Lunte CE. Microdialysis sampling in tumor and muscle: study of the disposition of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (SR 4233). Life Sci 1994; 55: 815-25
104. de Lange EC, de Vries JD, Zurcher C, et al. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm Res 1995; 12: 1924-31
105. Nakashima M, Shibata S, Tokunaga Y, et al. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma. J Pharm Pharmacol 1997; 49: 777-80
106. Behrens PF, Langemann H, Strohschein R, et al. Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study. J Neurooncol 2000; 47: 11-22
107. Darbin O, Lonjon M, Quentien MH, et al. In vivo study of tumor metabolism: an application of new multi-probe microdialysis system in the striatum of freely moving rats grafted with C6 cells. Brain Res 2000; 881: 121-7
108. Wang Q, Yang H, Miller DW, et al. Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem Biophys Res Commun 1995; 211: 719-26
109. Sakata A, Tamai I, Kawazu K, et al. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994; 48: 1989-92
110. Tsai TH, Lee CH, Yeh PH. Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis. Br J Pharmacol 2001; 134: 1245-52
111. Ma J, Pulfer S, Li S, et al. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 2001; 61: 5491-8
112. Teicher BA, Holden SA, Ara G, et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Cancer 1994; 57: 920-5
113. Teicher BA, Dupuis NP, Robinson MF, et al. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncol Res 1995; 7: 237-43
114. Lundstedt C, Stridbeck H, Andersson R, et al. Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 1991; 32: 518-20
115. Weiss H. Metastases caused by fine needle puncture [in German]. Ultraschall Med 1989; 10: 147-51
116. Thompson JF, Siebert GA, Anissimov YG, et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer 2001; 85: 157-65
117. Ekstrom PO, Giercksky KE, Andersen A, et al. Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis. Life Sci 1997; 61: PL275-PL280
118. Ekstrom PO, Andersen A, Saeter G, et al. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report. Cancer Chemother Pharmacol 1997; 39: 267-72
119. Wennberg AM, Larko O, Lonnroth P, et al. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin: a microdialysis and perfusion study. Clin Exp Dermatol 2000; 25: 317-22
120. De Micheli E, Alfieri A, Pinna G, et al. Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study. Adv Exp Med Biol 2000; 483: 621-5
121. Hunz M, Jetter A, Wilde S, et al. Plasma and tissue pharmacokinetics of epirubicine in nine patients with primary breast cancer. Eur J Clin Pharmacol 2001; 57: A31
122. Jain RK. Delivery of molecular medicine to solid tumors. Science 1996; 271: 1079-80
123. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039-51
124. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155: 739-52
125. Shah VP, Flynn GL, Yacobi A, et al. Bioequivalence of topical dermatological dosage forms: methods of evaluation of bioequivalence. Pharm Res 1998; 15: 167-71
126. Fang JY, Sung KC, Lin HH, et al. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm 1999; 178: 83-92
127. Benfeldt E, Serup J. Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999; 291: 517-26
128. Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm Res 2001; 18: 367-73
129. Ding P, Xu H, Wei G, et al. Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats. Biomed Chromatogr 2000; 14: 141-3
130. Ault JM, Riley CM, Meltzer NM, et al. Dermal microdialysis sampling in vivo. Pharm Res 1994; 11: 1631-9
131. Nakashima M, Zhao MF, Ohya H, et al. Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats. J Pharm Pharmacol 1996; 48: 1143-6
132. Matsuyama K, Nakashima M, Nakaboh Y, et al. Application of in vivo microdialysis to transdermal absorption of methotrexate in rats. Pharm Res 1994; 11: 684-6
133. Fang JY, Hsu LR, Huang YB, et al. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Int J Pharm 1999; 180: 137-49
134. Matsuyama K, Nakashima M, Ichikawa M, et al. In vivo microdialysis for the transdermal absorption of valproate in rats. Biol Pharm Bull 1994; 17: 1395-8
135. Murakami T, Yoshioka M, Yumoto R, et al. Topical delivery of keloid therapeutic drug, tranilast, by combined use of oleic acid and propylene glycol as a penetration enhancer: evaluation by skin microdialysis in rats. J Pharm Pharmacol 1998; 50: 49-54
136. Stagni G, O'Donnell D, Liu YJ, et al. Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis. J Control Release 2000; 63: 331-9
137. Anderson C, Andersson T, Boman A, et al. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Probl Dermatol 1996; 25: 37-46
138. Boelsma E, Anderson C, Karlsson AM, et al. Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo. Pharm Res 2000; 17: 141-7
139. Benfeldt E, Serup J, Menne T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999; 140: 739-48
140. Hegemann L, Forstinger C, Partsch B, et al. Microdialysis in cutaneous pharmacology: kinetic analysis of transdermally delivered nicotine. J Invest Dermatol 1995; 104: 839-43
141. Schrolnberger C, Brunner M, Mayer BX, et al. Application of the minimal trauma biopsy to transdermal clinical pharmacokinetic studies. J Control Release 2001; 75: 297-306
142. Tegeder I, Muth-Selbach U, Lotsch J, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther 1999; 65: 357-68
143. Anderson C, Andersson T, Molander M. Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol 1991; 71: 389-93
144. Stagni G, O'Donnell D, Liu YJ, et al. Iontophoretic current and intradermal microdialysis recovery in humans. J Pharmacol Toxicol Methods 1999; 41: 49-54
145. Benfeldt E. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration: studies in hairless rats and human subjects. Acta Derm Venereol Suppl (Stockh) 1999; 206: 1-59
146. Cormier M, Chao ST, Gupta SK, et al. Effect of transdermal iontophoresis codelivery of hydrocortisone on metoclopramide pharmacokinetics and skin-induced reactions in human subjects. J Pharm Sci 1999; 88: 1030-5
147. Boutsiouki P, Thompson JP, Clough GF. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch Toxicol 2001; 75: 321-8
148. Liu P, Muller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002; 19: 285-90
149. Meibohm B, Derendorf H. Pharmacokinetic/pharmacodynamic studies in drug product development. J Pharm Sci 2002; 91: 18-31
150. Delacher S, Derendorf H, Hollenstein U, et al. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother 2000; 46: 733-9
151. Sauermann R, Zeitlinger M, Erovic BM, et al. Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int J Antimicrob Agents 2003; 22: 574-8
152. Zeitlinger MA, Marsik C, Georgopoulos A, et al. Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. Int J Antimicrob Agents 2003; 21: 562-7
153. Muller M, Bockenheimer J, Zellenberg U, et al. Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients. Breast Cancer Res Treat 2000; 60: 211-7
154. Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000; 41: 661-81
155. Front D, Israel O, Iosilevsky G, et al. Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake. Radiology 1987; 165: 129-33
156. Sundram FX, Wong WY, Ang ES, et al. Evaluation of technetium-99m ciprofloxacin (Infecton) in the imaging of infection. Ann Acad Med Singapore 2000; 29: 699-703
157. Fischman AJ, Livni E, Babich J, et al. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother 1993; 37: 2144-52
158. Wollmer P, Pride NB, Rhodes CG, et al. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet 1982; II: 1361-4
159. Tewson TJ, Yang D, Wong G, et al. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies. Nucl Med Biol 1996; 23: 767-72
160. Jynge P, Skjetne T, Gribbestad I, et al. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther 1990; 48: 481-9
161. Fischman AJ, Alpert NM, Livni E, et al. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother 1993; 37: 1270-7
162. Fischman AJ, Alpert NM, Babich JW, et al. The role of positron emission tomography in pharmacokinetic analysis. Drug Metab Rev 1997; 29: 923-56